Brand Name(s): Anzemet
CAS nš: 115956-12-2
(dol a' se tron)
What is Dolasetron?
Dolasetron is a serotonin 5-HT3 receptor antagonist used to treat nausea and vomiting following chemotherapy or surgery.
Its main effect is to reduce the activity of the vagus nerve, which is a nerve that activates the vomiting center in the medulla oblongata. However, it does not have much effect on vomiting due to motion sickness.
Furthermore, this drug does not have any effect on dopamine receptors or muscarinic receptors.
Latest News
Inspired oxygen fraction of 0.8 compared with 0.4 does not further reduce postoperative nausea and vomiting in dolasetron-treated patients undergoing laparoscopic cholecystectomy.
Background. Postoperative nausea and vomiting (PONV) is one of the most frequent complications...
[more]Drugs for preventing postoperative nausea and vomiting
Patients coming out of anesthesia after surgery may experience nausea or vomiting, and are...
[more]Drugs given to stop nausea and vomiting after surgery help only a few people
Between 10 - 28% of people benefit from taking an anti-emetic drug to prevent nausea or vomiting...
[more]Drugs for Postoperative Nausea May Not Help Most Patients
Patients coming out of anesthesia after surgery may experience nausea or vomiting, and are...
[more]Lack of Effect of Aprepitant on Hydrodolasetron Pharmacokinetics in CYP2D6 Extensive and Poor Metabolizers
To prevent chemotherapy-induced nausea and vomiting, aprepitant is given with a corticosteroid and...
[more]